ClinicalTrials.gov
public full text
Public Domain
Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
Primary: * Overall Survival (OS) Secondary: * Time to Tumor Progression (TTP) * Response Rate (RR) * Improvement of Quality of Life (QoL) * Safety * Secondary resection rate
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Oxaliplatin in Unresectable Hepatocellular Carcinoma#813887
- Hepatic Artery Infusion With Oxaliplatin#890061
- Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer#812423
- Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil#880637
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer#1126732
Record · ID 855656
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive